HMGB1-CGK012

Yun Jin Park1, Jong Beom Heo2, Yoon-Jung Choi2

  • 1Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea.

概括

CGK012是一种新型化合物,在败血症模型中减少HMGB1释放和血管透性. 这种治疗改善了小鼠的存活率和组织学状况,表明作为败血症治疗方法的潜力.